Dr. Mori joined NATiAS in 2021 and is a director of Quality Assurance/CQO. Prior to NATiAS, he has started his carrier as a medicinal chemist at Novartis, and moved to GSK and Pfizer as a director of chemistry department in the area of central nervous disease, cancer, and intestinal disease. He then moved to Kobe University as a professor working on drug discovery projects in the field of diabetes, cancer, and Alzheimer disease. He received M.S from Kyoto University and then Ph.D from Department of Chemistry at U.C. Berkeley in 1988.